Home/Filings/4/0001415889-25-024442
4//SEC Filing

Turner Heather D 4

Accession 0001415889-25-024442

CIK 0001691082other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 6:25 PM ET

Size

15.0 KB

Accession

0001415889-25-024442

Insider Transaction Report

Form 4
Period: 2025-09-10
Turner Heather D
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-09-10+175,706175,706 total
    Exercise: $15.00Exp: 2034-11-17Common Stock (175,706 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2025-09-107,8570 total
    Exercise: $41.84Exp: 2035-01-13Common Stock (7,857 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2025-09-10175,7060 total
    Exercise: $41.84Exp: 2034-11-17Common Stock (175,706 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2025-09-10+971,828971,828 total
    Exercise: $15.00Exp: 2035-09-09Common Stock (971,828 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2025-09-10+7,8577,857 total
    Exercise: $15.00Exp: 2035-01-13Common Stock (7,857 underlying)
Footnotes (3)
  • [F1]One fourth (1/4) of the shares subject to the option award shall vest on November 18, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
  • [F2]The transactions reported herein reflect a one-time stock option repricing, effective on September 10, 2025, which reduced the per share exercise price of each repriced option to $15, representing the initial public offering price of the Issuer's common stock (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the repriced options, including, without limitation, any provisions with respect to vesting, remain in full force and effect.
  • [F3]One fourth (1/4) of the shares subject to the option award shall vest on September 10, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Issuer

LB PHARMACEUTICALS INC

CIK 0001691082

Entity typeother

Related Parties

1
  • filerCIK 0001403571

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 6:25 PM ET
Size
15.0 KB